Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.

Slides:



Advertisements
Similar presentations
Board Governance: A Key to Quality Organizations
Advertisements

Common/shared responsibilities between jobs.
Medication Management
Donald T. Simeon Caribbean Health Research Council
RATIONAL USE OF INJECTION: An Integrated Tool For Monitoring Injection Prescription in the Kingdom of CAMBODIA Dr Sok Srun Department of Hospitals, MoH.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
December 6, Exploring the Role of a PAC By the AB SpEd PAC.
NATIONAL EVALUATION OF MEDICINES DISPENSING WITHIN BRAZILIAN AIDS PROGRAM Third International Conference for Improving Use of Medicines Azeredo TB, Luiza.
“RAC 101” An Introduction to the AASHTO Research Advisory Committee 26 July 2010.
PHAB's Approach to Internal and External Evaluation Jessica Kronstadt | Director of Research and Evaluation | November 18, 2014 APHA 2014 Annual Meeting.
Australia’s Experience in Utilising Performance Information in Budget and Management Processes Mathew Fox Assistant Secretary, Budget Coordination Branch.
Quality Improvement Prepeared By Dr: Manal Moussa.
Mia Alexander-Snow, PhD Director, Office for Planning and Institutional Effectiveness Program Review Orientation 1.
Quality assurance in IVET in Romania Lucian Voinea Mihai Iacob Otilia Apostu 4 th Project Meeting Prague, 21 st -22 nd October 2010.
University Writing Project Faculty Feedback
Review of progress in implementing tasks assigned, impediments to implementation and solutions.
The New Role and New Mission of Cooperative Auditing Department in Thailand. Assist. Prof. Dr. Ratana Pothisuwan Assoc. Prof. Dr. Prasert Janyasupab Department.
REPORTING, MONITORING AND PERFORMANCE EVALUATION PROVISIONS ON NON-FINANCIALS – 2013/14 1 MIG Quarterly Workshop 3 – 4 September 2013.
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
University of Idaho Successful External Program Review Archie George, Director Institutional Research and Assessment Jane Baillargeon, Assistant Director.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
CONDUCTING A PUBLIC OUTREACH CAMPAIGN IMPLEMENTING LEAPS IN CENTRAL AND EASTERN EUROPE: TRAINERS’ HANDBOOK Conducting a Public Outreach Campaign.
EEC Board Preliminary Recommendations Quality Rating and Improvement System (QRIS) Provisional Standards Study.
AdvancED District Accreditation Process © 2010 AdvancED.
Building and Recognizing Quality School Systems DISTRICT ACCREDITATION © 2010 AdvancED.
Draft Transition Plan for the Transfer of the Drug Medi-Cal Treatment Program Fourth Series: Stakeholder Meetings Department of Health Care Services Department.
Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee.
Summary Over all services Some providers and clients were not aware of adverse effects of contraceptives and the possibility of sex transmitted diseases.
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
CHAPTER V Health Information. Updates on new legislation (1)  Decision No.1605/2010/QĐ-TTg approving the National Program for Application of information.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Benton-Franklin Community Health Alliance, Lourdes Health Network, Kadlec Regional Medical Center, Kennewick General Hospital, Group Health Cooperative,
ABSTRACT THE CHALLENGE OF INTEGRATING A RDU TRAINING MODEL INTO THE REALITY OF A HEALTH SYSTEM CONTEXT Problem Statement: The Dar es Salaam Urban Health.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
STRATEGIC PLANNING & WASC UPDATE Tom Bennett Presentation to Academic Senate February 1, 2006.
Budget Formulation 2017/2018 A review of the 2017 process and the 2018 process. Office of Budget and Performance Management November 2015.
Project financed under Phare EUROPEAN UNION QUALITY EXTERNAL MONITORING IN THE SCHOOL YEAR 2007 – 2008 CONCLUSIONS AND RECOMMENDATIONS Material produced.
Pethidine prescribing in the ED… Let’s be rational! Kaye KI, Maxwell DJ, Graudins L, on behalf of the the NSW Therapeutic Assessment Group (NSW TAG) Drug.
Unit 9: Evaluating a Public Health Surveillance System #1-9-1.
Multistate Research Program Roles & Responsibilities Eric Young SAAESD Meeting Corpus Christi, TX April 3-6, 2005.
R&D Annual Report SLaM Board, Sept 2004 Graham Thornicroft Gill Dale.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Establishing Effective Hospital Drug and Therapeutics Committees: a situational analysis Ndhlovu C E, Simoyi T National Drug and Therapeutics Policy Advisory.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
CHB Conference 2007 Planning for and Promoting Healthy Communities Roles and Responsibilities of Community Health Boards Presented by Carla Anglehart Director,
Karen Cheung, MPH, Pamela Luna, DrPH, MST, Sarah Merkle, MPH American Evaluation Association Annual Meeting November 11, 2009 The findings and conclusions.
Pharmacy in Public Health: Community Health Course, date, etc. info.
Technical Assistance Drive- In February 17, 2016.
Cañada College Professional Development Committee Determining Participants.
Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.
International Conference on Improving Use of Medicines
ROLES AND RESPONSIBILITIES OF VARIOUS LEVELS IN ESTABLISHING AND IMPLEMENTING THE ADDO PROGRAM August 2009.
Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.
Marlene Matosky and Susan Robilotto HIV/AIDS Bureau (HAB)
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Kandeke C, Chibuta C, Banda D
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
Abstract Impact of the National Healthcare Reform on Prescribing Patterns of Promotional Targeted Drugs among Thai Physicians Layton MR*, Chadbunchachai.
PH Dung, NTK Chuc and Dennis Ross Degan
ABSTRACT   Qualitative and Quantitative Assessment of the Essential Medicines List of Delhi State: A Time Series Analysis. Gupta U, Sangeeta S, Baishya.
Gauteng Provincial Legislature Money Bills Act Discussion
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K Institution: La Trobe University, Australia Title: Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Problem Statement: In Thailand, hospitals under the Office of the Permanent Secretary were first required to establish PTCs in At that time, a “Manual of Drug Administration” listed the expected structure, roles and responsibilities of PTCs. Since 1997, Thai hospitals have faced economic crisis, quality improvement and accreditation, universal coverage health reform and structural change in the Ministry of Public Health (MoPH). Objectives: To examine PTC performance during these changes and use the information obtained to suggest possible improvements. Design: Retrospective document review, in-depth interviews, questionnaire survey, a focus group, and participant observation. Setting and Study Population: This study was conducted from mid-December 2002 to mid-December Seventeen hospitals (2 regional hospitals, 3 provincial hospitals, and 12 district hospitals), in 4 regions of Thailand were studied. Ten key informants who were the Chairperson, the Secretary or members of PTCs in those hospitals were interviewed, as were 15 stakeholders. Questionnaires were distributed to 452 PTC Chairpersons and Secretaries respectively in 25 regional hospitals, 67 provincial hospitals and 360 district hospitals. Eight key participants participated in a focus group. PTCs in three regional hospitals were observed. Outcome Measures: PTC meetings, possible PTC performance indicators and factors that may improve PTC performance. Results: The questionnaire response rate was 36% from PTC Chairpersons and 66% from Secretaries. Around 90% of PTC Chairpersons were Hospital Directors and 90% of Secretaries were Heads of Pharmacy Department. The average of the number of PTC members in regional, provincial and district hospitals was 19, 20, and 10 members, respectively. In each fiscal year (from ), there were only 2-3 PTC meetings in regional or provincial hospitals because their PTC Chairpersons wanted to delay the selection of new or expensive drugs into hospital drug lists and also limit the hospital drug lists as required by MoPH. There were only 1-2 PTC meetings in district hospitals because problems relating to drugs were discussed at the monthly Administration Committee meeting. PTCs at all levels of hospital focused their activities on drug selection and budget as this was the main focus of the 1987 “Manual”. The recommended PTC performance indicators were the number of PTC meetings and the number of drug items in hospital drug lists. To extend PTCs function to areas such as rational drug use it is suggested that a revised manual containing practical guidance and additional performance indicators are needed, overseen by a responsible organisation. In addition, the role of PTCs should be included in the education programs in universities or colleges that produce health workers. A PTC network was also suggested in order to share experiences between Thai PTCs. Conclusions: A responsible organization that facilitated networking among PTCs, better education, and a revised PTC Manual that provided more practical help on rational drug use activities, including performance indicators, would help PTCs expand their activities. Study Funding: World Health Organization

Background In Thailand, hospitals under the Office of the Permanent Secretary were first required to establish Pharmacy and Therapeutics Committees (PTCs) in A Manual of Drug Administration (1987) listed the expected structure, roles and responsibilities of PTCs. Since 1997, Thai hospitals have faced economic crisis, quality improvement and accreditation, universal coverage health reform and structural change in the Ministry of Public Health (MoPH).

Objectives To examine PTC performance during this period of change and reform. To determine the opinion of the PTC Chairpersons and the PTC Secretaries about defining good PTC performance, ways to improving PTC performance, and possible PTC performance indicators. To create a Manual that provides more practical help on rational drug use activities, including performance indicators.

Methods Retrospective document review In-depth interviews Questionnaire survey A focus group Participant observation

Sample & methods Seventeen hospitals (2 regional hospitals, 3 provincial hospitals, and 12 district hospitals) in 4 regions of Thailand. Ten key informants who were the Chairperson, the Secretary or members of the PTC were interviewed. Fifteen key informants who involved with PTC or who are responsible for drug information centers were interviewed. Questionnaires were distributed to 452 PTC Chairpersons and Secretaries respectively in 25 regional hospitals, 67 provincial hospitals and 360 district hospitals. Eight key participants who were PTC stakeholders participated in a focus group. PTCs in 3 regional hospitals were observed.

Questionnaire results (1) The questionnaire response rate was 36% from PTC Chairpersons and 66% from Secretaries. Around 90% of PTC Chairpersons were Hospital Directors and 90% of Secretaries were Heads of Pharmacy Department. The average of the number of PTC members in regional, provincial and district hospitals was 19, 20, and 10 members, respectively. There were only 2-3 PTC meetings in regional or provincial hospitals and only 1- 2 PTC meetings in district hospitals during each fiscal year (from ).

Questionnaire results (2) The most important PTC performance indicators suggested by all PTC Chairpersons: –Is PTC responsible for considering and approving allocation of drug budget proposed by the Pharmacy section? –Does PTC have a document providing criteria for addition and deletion of drug in the hospital drug list? –Does PTC have a policy to develop or implement Clinical Practice Guidelines for common problems such as acute respiratory infection, diarrheal diseases, hypertension, diabetes, epilepsy, and antibiotic prophylaxis, etc.? –Does the PTC monitor Pharmacy drug dispensing to ensure it follows written standards of pharmacy professional practice? – Does PTC conduct satisfaction surveys on hospital staff to receive feedback on PTC performance?

Questionnaire results (3) The most important PTC performance indicators suggested by PTC Secretaries: –Does a document identifying goal, committee, objectives, and functions of PTC exists? –Is PTC authorised to select drugs to be included and excluded in the hospital drug list? –Does PTC monitor the percentage of drugs used outside hospital drug list? –Does the PTC monitor Pharmacy drug dispensing to ensure it follows written standards of pharmacy professional practice? –Does PTC have a policy to conduct satisfaction of patients/clients on the hospital treatment service?

Questionnaire results (4) When asked about the most important factor needed for the development of an effective PTC: – the Chairpersons said it was an effective PTC Secretary; while –the Secretaries said it was an effective PTC Chairperson. When asked about external factors that can contribute to improved performance of PTC both PTC Chairpersons and Secretaries in all hospitals agreed that the most important aspect was: –a national collaborative drug information center as a hub for information exchange between PTC for a decision making purpose. In addition, PTC Chairpersons and PTC Secretaries in regional hospitals noted that: –defining the function of PTC in the hospital accreditation criteria would be helpful.

Results (5) The retrospective document review, in-depth interviews, a focus group and participant observation noted that: –Under new structure of Ministry of Public Health, there was no distinctive responsible organization who support and monitor PTCs. –Some hospitals had not updated information about new PTC members, functions or responsibilities. –Most PTC activities still focused on drug selection and controlling drug budget. Activities on rational drug use were few. –Many PTCs had not set their own specific goals, objectives, role and responsibilities. –Often PTCs had no working plan and there was also no orientation about goal, objectives, role and responsibilities for PTC members. –Many suggested the need for a responsible organization (perhaps under the Department of Health Service Support) that would assist PTCs by: Updating Manual of PTC roles and responsibilities; Providing opportunities for PTC networking e.g. by web site &/or discussion groups; Providing information for PTC to make decisions; Supporting the incorporation of PTC performance indicators in hospital accreditation (Bureau of Inspection & Evaluation &/or The Institute of Hospital Quality Improvement& Accreditation); Encouraging Universities to provide educational programs.

Summary PTCs at all levels of hospital focused their activities on drug selection and budget as this was the main focus of the 1987 “Manual”. There were limited numbers of meetings of PTCs (1-2 in district hospitals; 2-3 in regional or provincial hospitals). The recommended PTC performance indicators were the number of PTC meetings and the number of drug items in hospital drug lists. Suggestions for improving PTC performance: –Setting a responsible organization; –Encouraging educational programs in universities; and –Providing national drug information center and PTC networking.

Conclusion & Policy Implications There is a need for a responsible organization (perhaps under the Department of Health Service Support) that would assist PTCs by : –Updating a Manual regarding PTC roles and responsibilities; –Providing opportunities for PTC networking e.g. by web site &/or discussion groups; –Providing information for PTC to make decisions; –Supporting the incorporation of PTC performance indicators in hospital accreditation monitored by: Bureau of Inspection & Evaluation &/or Institute of Hospital Quality Improvement; –Encouraging Universities to provide PTC educational programs.